Alternative Medicine Businesses Seeking Loan in Aveiro

Based in Aveiro, the company will specialise in GACP and GMP-compliant medicinal cannabis, catering to Europe's growing demand in the alternative medicine sector. - Having conducted R&D for over 4 years, the company is strategically positioned with INFARMED-approved licenses for import, export, and production of medicinal cannabis. - Situated on 2.4 hectares of land ready for infrastructure development, aiming to secure EUR 2 million to expedite project completion. - The company already has well-established client relationships and strategic partnerships, ensuring a fully integrated supply chain from cultivation to the sale of dried cannabis flowers to pharmaceutical clients. - The business holds no current loan obligations, relying instead on partner contributions for initial costs, highlighting a financially prudent approach. - Market trends indicate a rising global demand for medicinal cannabis, aligning with the company's operations and future growth potential. - Full operational readiness is projected within 12 months following the investment, promising swift returns for prospective investors. - Has an experienced internal and external team poised to commence operations upon receiving the necessary funding.

Based in Aveiro, the company will specialise in GACP and GMP-compliant medicinal cannabis, catering to Europe's growing demand in the alternative medicine sector. - Having conducted R&D for over 4 years, the company is strategically positioned with INFARMED-approved licenses for import, export, and production of medicinal cannabis. - Situated on 2.4 hectares of land ready for infrastructure development, aiming to secure EUR 2 million to expedite project completion. - The company already has well-established client relationships and strategic partnerships, ensuring a fully integrated supply chain from cultivation to the sale of dried cannabis flowers to pharmaceutical clients. - The business holds no current loan obligations, relying instead on partner contributions for initial costs, highlighting a financially prudent approach. - Market trends indicate a rising global demand for medicinal cannabis, aligning with the company's operations and future growth potential. - Full operational readiness is projected within 12 months following the investment, promising swift returns for prospective investors. - Has an experienced internal and external team poised to commence operations upon receiving the necessary funding.